Lumefantrine

From WikiMD's WELLNESSPEDIA

An antimalarial drug used in combination therapies

Lumefantrine

Lumefantrine






























Lumefantrine is an antimalarial drug used in combination with artemether to treat malaria. It is part of the artemisinin-based combination therapies (ACTs) recommended by the World Health Organization for the treatment of uncomplicated Plasmodium falciparum malaria.

Pharmacology[edit]

Lumefantrine is a lipophilic compound that is poorly soluble in water. It is absorbed in the gastrointestinal tract and is metabolized in the liver by the cytochrome P450 system, primarily by the enzyme CYP3A4. The drug has a long half-life, which helps in maintaining therapeutic levels in the blood for an extended period, thus aiding in the prevention of malaria recurrence.

Mechanism of Action[edit]

Lumefantrine works by interfering with the haem polymerization process in the Plasmodium parasites. This process is crucial for the parasite's survival as it detoxifies the free haem released during the digestion of hemoglobin. By inhibiting this process, lumefantrine causes the accumulation of toxic haem, leading to the death of the parasite.

Clinical Use[edit]

Lumefantrine is used in combination with artemether, marketed under the brand name Coartem. This combination is effective against chloroquine-resistant strains of Plasmodium falciparum. The combination therapy is administered orally and is typically given over a three-day course.

Side Effects[edit]

Common side effects of lumefantrine include headache, dizziness, anorexia, and nausea. Serious side effects are rare but may include allergic reactions and QT interval prolongation, which can lead to arrhythmias.

History[edit]

Lumefantrine was developed in the 1980s and was initially used in China. It gained international recognition after being included in the World Health Organization's List of Essential Medicines. The combination with artemether was developed to enhance efficacy and reduce the risk of resistance.

Related pages[edit]

  • Lumefantrine
    Lumefantrine

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Lumefantrine&oldid=6335931"